Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2011 (2011), Article ID 473640, 5 pages
http://dx.doi.org/10.4061/2011/473640
Clinical Study

Nonmotor Symptoms in Patients with PARK2 Mutations

1Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
2Japan Somnology Center, Neuropsychiatric Research Institute, 1-24-10 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan

Received 14 October 2010; Accepted 16 December 2010

Academic Editor: Irena Rektorova

Copyright © 2011 Asako Yoritaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kitada, S. Asakawa, N. Hattori et al., “Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism,” Nature, vol. 392, no. 6676, pp. 605–608, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. M. Mouradian, “Recent advances in the genetics and pathogenesis of Parkinson disease,” Neurology, vol. 58, no. 2, pp. 179–185, 2002. View at Google Scholar · View at Scopus
  3. S. Orimo, E. Ozawa, S. Nakade, T. Sugimoto, and H. Mizusawa, “123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 67, no. 2, pp. 189–194, 1999. View at Google Scholar · View at Scopus
  4. C. H. Hawkes, B. C. Shephard, and S. E. Daniel, “Olfactory dysfunction in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 62, no. 5, pp. 436–446, 1997. View at Google Scholar · View at Scopus
  5. C. H. Schenck, S. R. Bundlie, and M. W. Mahowald, “Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder,” Neurology, vol. 46, no. 2, pp. 388–393, 1996. View at Google Scholar · View at Scopus
  6. T. Hummel, B. Sekinger, S. R. Wolf, E. Pauli, and G. Kobal, “'Sniffin' sticks'. Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold,” Chemical Senses, vol. 22, no. 1, pp. 39–52, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. American Academy of Sleep Medicine, International Classification of Sleep Disorders: Diagnostic and Coding Manual, American Academy of Sleep Medicine, Westchester, Ill, USA, 2nd edition, 2005.
  8. A. Quattrone, A. Bagnato, G. Annesi et al., “Myocardial m123etaiodobenzylguanidine uptake in genetic Parkinson's disease,” Movement Disorders, vol. 23, no. 1, pp. 21–27, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Estorch, I. Carrió, L. Berná, J. López-Pousa, and G. Torres, “Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age,” Journal of Nuclear Cardiology, vol. 2, no. 2, pp. 126–132, 1995. View at Google Scholar · View at Scopus
  10. S. Tsuchimochi, N. Tamaki, S. Shirakawa et al., “Evaluation of myocardial distribution of iodine-123 labeled metaiodobenzylguanidine (123I-MIBG) in normal subjects,” Kakuigaku, vol. 31, no. 3, pp. 257–264, 1994. View at Google Scholar · View at Scopus
  11. S. Orimo, T. Uchihara, A. Nakamura et al., “Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease,” Brain, vol. 131, no. 3, pp. 642–650, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Suzuki, N. Hattori, S. Orimo et al., “Preserved myocardial [123I] metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report,” Movement Disorders, vol. 20, no. 5, pp. 634–636, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Orimo, T. Amino, M. Yokochi et al., “Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2,” Movement Disorders, vol. 20, no. 10, pp. 1350–1353, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. G. Kägi, C. Klein, N. W. Wood et al., “Nonmotor symptoms in Parkin gene-related parkinsonism,” Movement Disorders, vol. 25, no. 9, pp. 1279–1284, 2010. View at Publisher · View at Google Scholar · View at PubMed
  15. N. L. Khan, R. Katzenschlager, H. Watt et al., “Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease,” Neurology, vol. 62, no. 7, pp. 1224–1226, 2004. View at Google Scholar · View at Scopus
  16. D. Verbaan, S. Boesveldt, S. M. van Rooden et al., “Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?” Neurology, vol. 71, no. 23, pp. 1877–1882, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. Kumru, J. Santamaria, E. Tolosa et al., “Rapid eye movement sleep behavior disorder in parkinsonism with PARKIN mutations,” Annals of Neurology, vol. 56, no. 4, pp. 599–603, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. H. Mori, T. Kondo, M. Yokochi et al., “Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q,” Neurology, vol. 51, no. 3, pp. 890–892, 1998. View at Google Scholar · View at Scopus